Zanvastro (zilganersen)
Ionis Pharmaceuticals (IONS)
ApprovedSep 3, 2026
Marketer take
Alexander disease had no FDA-approved disease-specific therapy, so this is a category-creating rare neurology launch built on genetic diagnosis, leukodystrophy centers and advocacy groups.
- Sponsor company
- Ionis Pharmaceuticals (IONS)
- Indication
- To treat Alexander disease in pediatric and adult patients
- Therapeutic area
- Neurology, Rare disease
- Event
- FDA approval
- Date
- Sep 3, 2026
- Status
- Approved
- Source
- FDA page
- Last verified
- Nov 15, 2026
Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?